Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808079 · ClinicalTrials.gov registry record
Gene Analysis in Studying Susceptibility to Wilms Tumor
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 1
- Enrollment target
NCT01808079: Completed study, sponsored by Children's Oncology Group.
NCT01808079 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01808079 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This clinical trial studies gene analysis in studying susceptibility to Wilms tumor. Finding genetic markers for Wilms tumor may help identify patients who are at risk of relapse.
Primary Outcome
Compared using the Cochran Armitage trend test (1-df). The data will be analyzed individually for the UK/US study populations and combined using a Mantel-Haenszel analysis adjusting for study group, and related methods which allow for different effects in each population (for confirmed loci, we will compare effects across populations).
Interventions
- OTHER Laboratory Biomarker Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2009-10 |
| Est. Completion | 2009-11 |
What the finished NCT01808079 record still lists
NCT01808079 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Laboratory Biomarker Analysis is the first listed.
NCT01808079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01808079 about?
NCT01808079 is a clinical study titled "Gene Analysis in Studying Susceptibility to Wilms Tumor". This clinical trial studies gene analysis in studying susceptibility to Wilms tumor. Finding genetic markers for Wilms tumor may help identify patients who are at risk of relapse.
What is the current status of trial NCT01808079?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2009-10. Estimated completion is 2009-11.
What interventions are being tested in trial NCT01808079?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT01808079?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia